首页 > 最新文献

Psychotic Disorders最新文献

英文 中文
First-episode psychosis 首发精神病
Pub Date : 2020-10-01 DOI: 10.1093/med/9780190653279.003.0015
M. Nordentoft, N. Albert
Psychosis in the schizophrenia spectrum constitutes a major public health problem. There is convincing evidence for positive effects of 2-year specialized early intervention programs with intensive care, assertive outreach, and family involvement. Follow-up studies indicate a risk of loss of positive clinical effects after termination of specialized programs, but clinical effects can be sustained or even improved with prolonged specialized treatment or transfer to standard treatment, including assertive community treatment (ACT) for the most disabled patients. Long-term studies show substantial heterogeneity in clinical and functional outcomes, resulting in a very diverse picture. Ten-year follow-up studies of the OPUS and the AESOP cohort indicate that more than half of the patients will achieve stable remission of psychotic symptoms and that half of those patients can maintain remission in the long run without antipsychotic medication.
精神分裂症谱系中的精神病构成了一个重大的公共卫生问题。有令人信服的证据表明,为期2年的专业早期干预项目具有积极的效果,包括重症监护、自信的外展和家庭参与。随访研究表明,终止专业项目后有丧失积极临床效果的风险,但临床效果可以通过延长专业治疗或转移到标准治疗来维持甚至改善,包括针对大多数残疾患者的果断社区治疗(ACT)。长期研究显示临床和功能结果存在很大的异质性,导致了非常多样化的情况。对OPUS和AESOP队列的10年随访研究表明,超过一半的患者将实现精神病症状的稳定缓解,其中一半的患者可以在不使用抗精神病药物的情况下长期保持缓解。
{"title":"First-episode psychosis","authors":"M. Nordentoft, N. Albert","doi":"10.1093/med/9780190653279.003.0015","DOIUrl":"https://doi.org/10.1093/med/9780190653279.003.0015","url":null,"abstract":"Psychosis in the schizophrenia spectrum constitutes a major public health problem. There is convincing evidence for positive effects of 2-year specialized early intervention programs with intensive care, assertive outreach, and family involvement. Follow-up studies indicate a risk of loss of positive clinical effects after termination of specialized programs, but clinical effects can be sustained or even improved with prolonged specialized treatment or transfer to standard treatment, including assertive community treatment (ACT) for the most disabled patients. Long-term studies show substantial heterogeneity in clinical and functional outcomes, resulting in a very diverse picture. Ten-year follow-up studies of the OPUS and the AESOP cohort indicate that more than half of the patients will achieve stable remission of psychotic symptoms and that half of those patients can maintain remission in the long run without antipsychotic medication.","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128019979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epilepsy and psychosis 癫痫和精神病
Pub Date : 2020-10-01 DOI: 10.1093/med/9780190653279.003.0011
M. Trimble, K. Kanemoto, D. Hesdorffer
This chapter reviews the important place that epilepsy has had in developing concepts of psychosis in general and for understanding some of the basic biological issues of schizophrenia and bipolar disorder. It starts out by offering a historical introduction noting important observations stemming from the nineteenth century. It reviews the complexity of classification in this area, highlighting in particular problems with Diagnostic and Statistical Manual, 5th edition (DSM-5). Epidemiology is followed by brief discussions of the relationship between seizures and psychosis, commenting on some paradoxes revealing why postictal psychoses are underdiagnosed, and the pitfalls of missing forced normalization, a concept that relates to the worsening of behavior with the cessation of seizures in people with intractable epilepsy. Finally, the chapter provides some guides to management of patients with epilepsy who have comorbid psychiatric disorders.
本章回顾了癫痫在发展精神病概念中的重要地位,以及对精神分裂症和双相情感障碍的一些基本生物学问题的理解。它首先提供了一个历史介绍,指出了19世纪的重要观察。它回顾了这一领域分类的复杂性,突出了诊断和统计手册第5版(DSM-5)的特定问题。在流行病学之后,简要讨论了癫痫发作和精神病之间的关系,评论了一些悖论,揭示了为什么后发精神病未得到充分诊断,以及缺少强制正常化的陷阱,强制正常化的概念与难治性癫痫患者癫痫发作停止时行为恶化有关。最后,本章提供了一些指导管理癫痫患者谁有共病精神障碍。
{"title":"Epilepsy and psychosis","authors":"M. Trimble, K. Kanemoto, D. Hesdorffer","doi":"10.1093/med/9780190653279.003.0011","DOIUrl":"https://doi.org/10.1093/med/9780190653279.003.0011","url":null,"abstract":"This chapter reviews the important place that epilepsy has had in developing concepts of psychosis in general and for understanding some of the basic biological issues of schizophrenia and bipolar disorder. It starts out by offering a historical introduction noting important observations stemming from the nineteenth century. It reviews the complexity of classification in this area, highlighting in particular problems with Diagnostic and Statistical Manual, 5th edition (DSM-5). Epidemiology is followed by brief discussions of the relationship between seizures and psychosis, commenting on some paradoxes revealing why postictal psychoses are underdiagnosed, and the pitfalls of missing forced normalization, a concept that relates to the worsening of behavior with the cessation of seizures in people with intractable epilepsy. Finally, the chapter provides some guides to management of patients with epilepsy who have comorbid psychiatric disorders.","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128230522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Animal models of psychosis 精神病动物模型
Pub Date : 2020-10-01 DOI: 10.1093/med/9780190653279.003.0055
D. Scott
The creation of a valid animal model is of crucial importance to the study of the biological mechanisms underlying disease pathophysiology. This becomes difficult when studying psychiatric illness, most especially psychosis, as humans’ mental state is a strictly internally experienced phenomenon, and thus the biological readout of these conditions is often a behavioral assessment. Therefore, when designing appropriate animal model systems and behavioral assessments for the study of psychiatric illness, it is necessary that appropriate measures be taken to ensure the systems and tasks used fulfill rigorous demands of validity. This chapter discusses different forms of validity, expanding on the classical validity measures of face, predictive, and construct validity. Specific examples of behavioral assessments and animal preparations that adhere to these specific definitions of validity are presented. These include specific experimental paradigms that can be similarly assessed in humans with psychosis and animal models, methods to create an animal preparation based on known psychosis triggers and risk factors, and pharmacological means to demonstrate relevance to the human condition. The chapter argues for a systematic approach to design, verify, and validate an animal model system for research into psychosis specifically, and other psychiatric disorders more generally, based on these different classes of validity.
建立有效的动物模型对于研究疾病病理生理的生物学机制至关重要。这在研究精神疾病时变得困难,尤其是精神病,因为人类的精神状态是一种严格的内部体验现象,因此这些条件的生物学读数通常是一种行为评估。因此,在为精神疾病研究设计合适的动物模型系统和行为评估时,有必要采取适当的措施,确保所使用的系统和任务满足严格的有效性要求。本章讨论了不同形式的效度,扩展了经典的效度测量,如面孔效度、预测效度和构念效度。具体的例子,行为评估和动物制剂,坚持这些特定的有效性定义提出。这些包括可以在精神病患者和动物模型中进行类似评估的特定实验范式,基于已知精神病诱因和风险因素创建动物制剂的方法,以及证明与人类状况相关的药理学手段。本章提出了一种系统的方法来设计、验证和验证动物模型系统,用于研究精神病,以及更广泛的其他精神疾病,基于这些不同的有效性类别。
{"title":"Animal models of psychosis","authors":"D. Scott","doi":"10.1093/med/9780190653279.003.0055","DOIUrl":"https://doi.org/10.1093/med/9780190653279.003.0055","url":null,"abstract":"The creation of a valid animal model is of crucial importance to the study of the biological mechanisms underlying disease pathophysiology. This becomes difficult when studying psychiatric illness, most especially psychosis, as humans’ mental state is a strictly internally experienced phenomenon, and thus the biological readout of these conditions is often a behavioral assessment. Therefore, when designing appropriate animal model systems and behavioral assessments for the study of psychiatric illness, it is necessary that appropriate measures be taken to ensure the systems and tasks used fulfill rigorous demands of validity. This chapter discusses different forms of validity, expanding on the classical validity measures of face, predictive, and construct validity. Specific examples of behavioral assessments and animal preparations that adhere to these specific definitions of validity are presented. These include specific experimental paradigms that can be similarly assessed in humans with psychosis and animal models, methods to create an animal preparation based on known psychosis triggers and risk factors, and pharmacological means to demonstrate relevance to the human condition. The chapter argues for a systematic approach to design, verify, and validate an animal model system for research into psychosis specifically, and other psychiatric disorders more generally, based on these different classes of validity.","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130185040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive-behavioral therapy 认知行为疗法
Pub Date : 2020-10-01 DOI: 10.1093/med/9780190653279.003.0057
T. Lincoln, A. Brabban
The view that psychotic symptoms lie on a continuum with normal experiences and can be explained by normal psychological processes has provided the basis for adapting cognitive-behavioral interventions for psychosis. Cognitive-behavioral therapy for psychosis (CBTp) focuses on reframing appraisals and modifying behavior related to psychotic symptoms to reduce distress and improve functioning and well-being. To date, the efficacy and effectiveness of CBTp has been demonstrated in over 30 intervention trials and it is widely recommended in various national treatment guidelines. This introduction to CBTp provides an overview of the main strategies employed including interventions for building rapport, developing and working with a shared case formulation, enhancing patients’ use of coping strategies for disabling and distressing symptoms, working with beliefs seen as maintaining hallucinations, delusions and negative symptoms as well as strategies for preventing relapse. It also briefly summarizes the current evidence base for CBTp and point out further developments.
精神病症状与正常经历是一个连续体,可以用正常的心理过程来解释,这一观点为精神病的认知行为干预提供了基础。精神病的认知行为疗法(CBTp)侧重于重新构建评估和修改与精神病症状相关的行为,以减少痛苦,改善功能和幸福感。迄今为止,CBTp的疗效和有效性已在30多项干预试验中得到证实,并在各种国家治疗指南中得到广泛推荐。对CBTp的介绍概述了所采用的主要策略,包括建立融洽关系的干预措施,制定和使用共同的案例提法,加强患者对残疾和痛苦症状的应对策略的使用,处理被视为维持幻觉、妄想和消极症状的信念,以及预防复发的策略。它还简要总结了目前CBTp的证据基础,并指出了进一步的发展。
{"title":"Cognitive-behavioral therapy","authors":"T. Lincoln, A. Brabban","doi":"10.1093/med/9780190653279.003.0057","DOIUrl":"https://doi.org/10.1093/med/9780190653279.003.0057","url":null,"abstract":"The view that psychotic symptoms lie on a continuum with normal experiences and can be explained by normal psychological processes has provided the basis for adapting cognitive-behavioral interventions for psychosis. Cognitive-behavioral therapy for psychosis (CBTp) focuses on reframing appraisals and modifying behavior related to psychotic symptoms to reduce distress and improve functioning and well-being. To date, the efficacy and effectiveness of CBTp has been demonstrated in over 30 intervention trials and it is widely recommended in various national treatment guidelines.\u0000 This introduction to CBTp provides an overview of the main strategies employed including interventions for building rapport, developing and working with a shared case formulation, enhancing patients’ use of coping strategies for disabling and distressing symptoms, working with beliefs seen as maintaining hallucinations, delusions and negative symptoms as well as strategies for preventing relapse. It also briefly summarizes the current evidence base for CBTp and point out further developments.","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"161 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132394299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Migration, ethnicity, and psychoses
Pub Date : 2020-10-01 DOI: 10.1093/med/9780190653279.003.0047
C. Morgan
The incidence of psychotic disorders is increased, to varying extents, in many migrant and minority ethnic populations in several countries. This chapter briefly reviews the evidence on disparities in incidence between minority and majority populations and then discusses possible explanations. It is unlikely that methodological artifact, including misdiagnosis, can fully account for the high incidence rates observed in some populations. Further, there is no evidence that established neurodevelopmental risk factors for psychosis explain disparities among ethnic groups. It is, then, most likely—and there is growing evidence to support this—that the high rates are a consequence of greater exposure to adverse social conditions and experiences, particularly those involving threat and violence, over the life course among minority ethnic groups. In other words, psychosis occurs more often in some minority populations via a socio-developmental pathway.
在一些国家的许多移民和少数民族人口中,精神疾病的发病率在不同程度上有所增加。本章简要回顾了少数民族和多数人口之间发病率差异的证据,然后讨论了可能的解释。包括误诊在内的方法学错误不太可能完全解释在某些人群中观察到的高发病率。此外,没有证据表明精神病的神经发育风险因素可以解释种族间的差异。那么,最有可能的是——而且有越来越多的证据支持这一观点——在少数民族群体的生命历程中,高比率是更多地暴露于不利的社会条件和经历,特别是那些涉及威胁和暴力的社会条件和经历的结果。换句话说,精神病通过社会发展途径更常发生在一些少数民族人群中。
{"title":"Migration, ethnicity, and psychoses","authors":"C. Morgan","doi":"10.1093/med/9780190653279.003.0047","DOIUrl":"https://doi.org/10.1093/med/9780190653279.003.0047","url":null,"abstract":"The incidence of psychotic disorders is increased, to varying extents, in many migrant and minority ethnic populations in several countries. This chapter briefly reviews the evidence on disparities in incidence between minority and majority populations and then discusses possible explanations. It is unlikely that methodological artifact, including misdiagnosis, can fully account for the high incidence rates observed in some populations. Further, there is no evidence that established neurodevelopmental risk factors for psychosis explain disparities among ethnic groups. It is, then, most likely—and there is growing evidence to support this—that the high rates are a consequence of greater exposure to adverse social conditions and experiences, particularly those involving threat and violence, over the life course among minority ethnic groups. In other words, psychosis occurs more often in some minority populations via a socio-developmental pathway.","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"888 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130126882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Family interventions in psychosis 精神病的家庭干预
Pub Date : 2020-10-01 DOI: 10.1007/978-3-642-45257-4_13
J. Onwumere, E. Hunter, E. Kuipers
{"title":"Family interventions in psychosis","authors":"J. Onwumere, E. Hunter, E. Kuipers","doi":"10.1007/978-3-642-45257-4_13","DOIUrl":"https://doi.org/10.1007/978-3-642-45257-4_13","url":null,"abstract":"","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124095002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjunctive Medications 辅助药物
Pub Date : 2019-12-05 DOI: 10.1007/978-3-030-29450-2_19
O. Freudenreich
{"title":"Adjunctive Medications","authors":"O. Freudenreich","doi":"10.1007/978-3-030-29450-2_19","DOIUrl":"https://doi.org/10.1007/978-3-030-29450-2_19","url":null,"abstract":"","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"136 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131428454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual Diagnosis 双重诊断
Pub Date : 2019-12-05 DOI: 10.1007/978-3-030-29450-2_26
O. Freudenreich
{"title":"Dual Diagnosis","authors":"O. Freudenreich","doi":"10.1007/978-3-030-29450-2_26","DOIUrl":"https://doi.org/10.1007/978-3-030-29450-2_26","url":null,"abstract":"","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123655358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Negative Symptoms 阴性症状
Pub Date : 2019-12-05 DOI: 10.1007/978-3-030-29450-2_28
O. Freudenreich
{"title":"Negative Symptoms","authors":"O. Freudenreich","doi":"10.1007/978-3-030-29450-2_28","DOIUrl":"https://doi.org/10.1007/978-3-030-29450-2_28","url":null,"abstract":"","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122007786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 67
Drug-Induced Psychosis 药物引起的精神病
Pub Date : 2019-12-05 DOI: 10.1007/978-3-030-29450-2_4
O. Freudenreich
{"title":"Drug-Induced Psychosis","authors":"O. Freudenreich","doi":"10.1007/978-3-030-29450-2_4","DOIUrl":"https://doi.org/10.1007/978-3-030-29450-2_4","url":null,"abstract":"","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122444206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Psychotic Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1